CN Stock MarketDetailed Quotes

Hunan Dajiaweikang Pharmaceutical Industry (301126)

Watchlist
  • 11.71
  • -0.10-0.85%
Market Closed May 15 15:00 CST
2.41BMarket Cap-10.03P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Hunan Dajiaweikang Pharmaceutical Industry (301126) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
Total operating revenue
6.49%1.38B
-1.70%5.14B
3.69%4.13B
4.16%2.71B
1.51%1.3B
34.07%5.23B
43.43%3.98B
46.95%2.6B
46.06%1.28B
18.56%3.9B
Operating revenue
6.49%1.38B
-1.70%5.14B
3.69%4.13B
4.16%2.71B
1.51%1.3B
34.07%5.23B
43.43%3.98B
46.95%2.6B
46.06%1.28B
18.56%3.9B
Other operating revenue
----
26.48%16.86M
----
7.93%18.79M
----
42.31%13.33M
----
331.62%17.41M
----
-30.61%9.37M
Total operating cost
6.12%1.37B
0.44%5.19B
4.56%4.1B
5.82%2.7B
3.56%1.29B
34.27%5.16B
43.83%3.92B
47.44%2.55B
48.00%1.25B
20.06%3.85B
Operating cost
6.57%1.15B
0.35%4.21B
6.44%3.43B
7.57%2.26B
3.97%1.08B
26.05%4.19B
34.29%3.22B
38.37%2.1B
38.63%1.03B
14.86%3.33B
Operating tax surcharges
-23.56%4.02M
18.96%22.49M
10.19%16.05M
3.38%9.85M
16.62%5.26M
32.90%18.91M
42.05%14.57M
76.62%9.53M
76.94%4.51M
22.82%14.23M
Operating expense
7.71%153.02M
-1.74%646.64M
-3.72%443.97M
-3.85%288.34M
-3.60%142.06M
104.54%658.12M
133.08%461.11M
135.09%299.88M
152.84%147.37M
79.20%321.76M
Administration expense
5.99%44.51M
8.17%180.53M
-10.95%122.24M
-5.57%79.05M
11.36%41.99M
63.04%166.9M
102.04%137.27M
82.65%83.71M
79.58%37.71M
32.84%102.37M
Financial expense
-14.12%21.85M
6.30%117.03M
5.42%80.65M
10.60%53.49M
11.97%25.44M
49.88%110.1M
55.93%76.51M
54.90%48.36M
50.93%22.72M
92.96%73.46M
-Interest expense (Financial expense)
----
8.27%106.76M
6.97%73.59M
12.30%48.84M
----
56.26%98.6M
--68.79M
50.05%43.49M
----
68.50%63.1M
-Interest Income (Financial expense)
----
6.55%-3.31M
9.96%-4.55M
0.99%-3.12M
----
33.21%-3.54M
---5.06M
-11.44%-3.15M
----
28.52%-5.3M
Research and development
-6.66%2.91M
-27.12%11.85M
-17.64%9.36M
-0.12%8.01M
50.98%3.11M
126.64%16.26M
274.03%11.36M
474.86%8.02M
186.31%2.06M
1,268.85%7.17M
Credit Impairment Loss
-23.95%-8.09M
-230.59%-30.45M
-11.22%-22.79M
-3.68%-13.53M
34.20%-6.52M
38.26%-9.21M
0.31%-20.49M
-10.74%-13.05M
2.87%-9.91M
10.91%-14.92M
Asset Impairment Loss
--347.38K
-1,392.21%-195.85M
-73.17%238.1K
-108.76%-77.78K
----
-115.93%-13.12M
--887.44K
--887.44K
----
-156.00%-6.08M
Other net revenue
-101.74%-72.11K
-2,262.86%-173.96M
487.05%5.09M
895.15%6.33M
171.90%4.15M
214.74%8.04M
106.17%867.1K
107.56%636.13K
37.52%-5.78M
42.99%-7.01M
Fair value change income
----
--16.21M
----
----
----
----
----
----
----
----
Invest income
--70.38K
1.71%-370.75K
-56.44%160.28K
--160.28K
----
-152.11%-377.18K
-42.17%367.92K
----
----
-146.79%-149.61K
-Including: Investment income associates
----
----
----
----
----
-164.74%-389.54K
----
----
----
--601.66K
Asset deal income
-201.97%-445.07K
30.47%1.81M
436.43%2.4M
2,173.44%1.6M
319.47%436.46K
25.10%1.38M
-59.45%447.31K
-55.64%70.47K
-220.38%-198.87K
245.11%1.11M
Other revenue
-21.49%8.04M
18.13%34.69M
27.61%25.09M
42.79%18.18M
136.30%10.24M
125.44%29.37M
312.40%19.66M
394.59%12.73M
334.50%4.33M
110.76%13.03M
Operating profit
9.57%12.05M
-377.26%-216.17M
-43.21%36.28M
-68.74%15.7M
-58.03%11M
53.24%77.96M
70.45%63.89M
61.41%50.21M
9.74%26.21M
-33.91%50.88M
Add:Non operating Income
-79.02%34.46K
-60.23%960.52K
-70.40%640.3K
-69.11%542.59K
-71.16%164.28K
1,192.70%2.42M
480.71%2.16M
1,108.83%1.76M
1,228.59%569.62K
46.38%186.82K
Less:Non operating expense
103.51%638.21K
19.07%5.22M
125.21%3.81M
59.03%2.35M
-25.85%313.6K
74.56%4.38M
80.62%1.69M
106.99%1.48M
7.56%422.94K
168.75%2.51M
Total profit
5.51%11.45M
-390.05%-220.43M
-48.56%33.11M
-72.49%13.89M
-58.83%10.85M
56.52%76M
74.33%64.36M
65.32%50.49M
12.00%26.36M
-36.26%48.55M
Less:Income tax cost
437.74%1.21M
-66.25%8.32M
-49.71%7.97M
-108.40%-873.65K
-94.76%225.29K
133.90%24.66M
88.69%15.85M
35.17%10.4M
-7.28%4.3M
-49.43%10.54M
Net profit
-3.65%10.24M
-545.64%-228.75M
-48.18%25.14M
-63.18%14.76M
-51.83%10.63M
35.05%51.33M
70.10%48.51M
75.48%40.09M
16.73%22.06M
-31.30%38.01M
Net profit from continuing operation
-3.65%10.24M
-545.64%-228.75M
-48.18%25.14M
-63.18%14.76M
-51.83%10.63M
35.05%51.33M
70.10%48.51M
75.48%40.09M
16.73%22.06M
-31.30%38.01M
Less:Minority Profit
-42.88%4.27M
-44.63%13.71M
66.16%20.04M
67.93%13.87M
185.25%7.48M
567.55%24.76M
156.45%12.06M
77.18%8.26M
-27.36%2.62M
-12.65%3.71M
Net profit of parent company owners
89.70%5.96M
-1,012.36%-242.46M
-86.02%5.1M
-97.19%893.53K
-83.82%3.14M
-22.52%26.57M
53.04%36.45M
75.04%31.83M
27.14%19.44M
-32.85%34.3M
Earning per share
Basic earning per share
50.00%0.03
-1,007.69%-1.18
-86.11%0.025
-97.33%0.004
-77.78%0.02
-23.53%0.13
50.00%0.18
66.67%0.15
28.57%0.09
-32.00%0.17
Diluted earning per share
50.00%0.03
-1,007.69%-1.18
-86.11%0.025
-97.33%0.004
-77.78%0.02
-23.53%0.13
50.00%0.18
66.67%0.15
28.57%0.09
-32.00%0.17
Other composite income
-1.86%1.22M
-4.31%1.24M
1.3M
Other composite income of parent company owners
----
-1.86%1.22M
----
----
----
-4.31%1.24M
----
----
----
--1.3M
Other composite income of minority owners
----
-1.87%123.58
----
----
----
-4.30%125.93
----
----
----
--131.59
Total composite income
-3.65%10.24M
-532.80%-227.53M
-48.18%25.14M
-63.18%14.76M
-51.83%10.63M
33.75%52.57M
70.10%48.51M
75.48%40.09M
16.73%22.06M
-28.95%39.31M
Total composite income of parent company owners
89.70%5.96M
-967.26%-241.24M
-86.02%5.1M
-97.19%893.53K
-83.82%3.14M
-21.86%27.82M
53.04%36.45M
75.04%31.83M
27.14%19.44M
-30.31%35.6M
Total composite income of minority owners
-42.88%4.27M
-44.62%13.71M
66.16%20.04M
67.93%13.87M
185.25%7.48M
567.53%24.76M
156.45%12.06M
77.18%8.26M
-27.36%2.62M
-12.65%3.71M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023
Total operating revenue 6.49%1.38B-1.70%5.14B3.69%4.13B4.16%2.71B1.51%1.3B34.07%5.23B43.43%3.98B46.95%2.6B46.06%1.28B18.56%3.9B
Operating revenue 6.49%1.38B-1.70%5.14B3.69%4.13B4.16%2.71B1.51%1.3B34.07%5.23B43.43%3.98B46.95%2.6B46.06%1.28B18.56%3.9B
Other operating revenue ----26.48%16.86M----7.93%18.79M----42.31%13.33M----331.62%17.41M-----30.61%9.37M
Total operating cost 6.12%1.37B0.44%5.19B4.56%4.1B5.82%2.7B3.56%1.29B34.27%5.16B43.83%3.92B47.44%2.55B48.00%1.25B20.06%3.85B
Operating cost 6.57%1.15B0.35%4.21B6.44%3.43B7.57%2.26B3.97%1.08B26.05%4.19B34.29%3.22B38.37%2.1B38.63%1.03B14.86%3.33B
Operating tax surcharges -23.56%4.02M18.96%22.49M10.19%16.05M3.38%9.85M16.62%5.26M32.90%18.91M42.05%14.57M76.62%9.53M76.94%4.51M22.82%14.23M
Operating expense 7.71%153.02M-1.74%646.64M-3.72%443.97M-3.85%288.34M-3.60%142.06M104.54%658.12M133.08%461.11M135.09%299.88M152.84%147.37M79.20%321.76M
Administration expense 5.99%44.51M8.17%180.53M-10.95%122.24M-5.57%79.05M11.36%41.99M63.04%166.9M102.04%137.27M82.65%83.71M79.58%37.71M32.84%102.37M
Financial expense -14.12%21.85M6.30%117.03M5.42%80.65M10.60%53.49M11.97%25.44M49.88%110.1M55.93%76.51M54.90%48.36M50.93%22.72M92.96%73.46M
-Interest expense (Financial expense) ----8.27%106.76M6.97%73.59M12.30%48.84M----56.26%98.6M--68.79M50.05%43.49M----68.50%63.1M
-Interest Income (Financial expense) ----6.55%-3.31M9.96%-4.55M0.99%-3.12M----33.21%-3.54M---5.06M-11.44%-3.15M----28.52%-5.3M
Research and development -6.66%2.91M-27.12%11.85M-17.64%9.36M-0.12%8.01M50.98%3.11M126.64%16.26M274.03%11.36M474.86%8.02M186.31%2.06M1,268.85%7.17M
Credit Impairment Loss -23.95%-8.09M-230.59%-30.45M-11.22%-22.79M-3.68%-13.53M34.20%-6.52M38.26%-9.21M0.31%-20.49M-10.74%-13.05M2.87%-9.91M10.91%-14.92M
Asset Impairment Loss --347.38K-1,392.21%-195.85M-73.17%238.1K-108.76%-77.78K-----115.93%-13.12M--887.44K--887.44K-----156.00%-6.08M
Other net revenue -101.74%-72.11K-2,262.86%-173.96M487.05%5.09M895.15%6.33M171.90%4.15M214.74%8.04M106.17%867.1K107.56%636.13K37.52%-5.78M42.99%-7.01M
Fair value change income ------16.21M--------------------------------
Invest income --70.38K1.71%-370.75K-56.44%160.28K--160.28K-----152.11%-377.18K-42.17%367.92K---------146.79%-149.61K
-Including: Investment income associates ---------------------164.74%-389.54K--------------601.66K
Asset deal income -201.97%-445.07K30.47%1.81M436.43%2.4M2,173.44%1.6M319.47%436.46K25.10%1.38M-59.45%447.31K-55.64%70.47K-220.38%-198.87K245.11%1.11M
Other revenue -21.49%8.04M18.13%34.69M27.61%25.09M42.79%18.18M136.30%10.24M125.44%29.37M312.40%19.66M394.59%12.73M334.50%4.33M110.76%13.03M
Operating profit 9.57%12.05M-377.26%-216.17M-43.21%36.28M-68.74%15.7M-58.03%11M53.24%77.96M70.45%63.89M61.41%50.21M9.74%26.21M-33.91%50.88M
Add:Non operating Income -79.02%34.46K-60.23%960.52K-70.40%640.3K-69.11%542.59K-71.16%164.28K1,192.70%2.42M480.71%2.16M1,108.83%1.76M1,228.59%569.62K46.38%186.82K
Less:Non operating expense 103.51%638.21K19.07%5.22M125.21%3.81M59.03%2.35M-25.85%313.6K74.56%4.38M80.62%1.69M106.99%1.48M7.56%422.94K168.75%2.51M
Total profit 5.51%11.45M-390.05%-220.43M-48.56%33.11M-72.49%13.89M-58.83%10.85M56.52%76M74.33%64.36M65.32%50.49M12.00%26.36M-36.26%48.55M
Less:Income tax cost 437.74%1.21M-66.25%8.32M-49.71%7.97M-108.40%-873.65K-94.76%225.29K133.90%24.66M88.69%15.85M35.17%10.4M-7.28%4.3M-49.43%10.54M
Net profit -3.65%10.24M-545.64%-228.75M-48.18%25.14M-63.18%14.76M-51.83%10.63M35.05%51.33M70.10%48.51M75.48%40.09M16.73%22.06M-31.30%38.01M
Net profit from continuing operation -3.65%10.24M-545.64%-228.75M-48.18%25.14M-63.18%14.76M-51.83%10.63M35.05%51.33M70.10%48.51M75.48%40.09M16.73%22.06M-31.30%38.01M
Less:Minority Profit -42.88%4.27M-44.63%13.71M66.16%20.04M67.93%13.87M185.25%7.48M567.55%24.76M156.45%12.06M77.18%8.26M-27.36%2.62M-12.65%3.71M
Net profit of parent company owners 89.70%5.96M-1,012.36%-242.46M-86.02%5.1M-97.19%893.53K-83.82%3.14M-22.52%26.57M53.04%36.45M75.04%31.83M27.14%19.44M-32.85%34.3M
Earning per share
Basic earning per share 50.00%0.03-1,007.69%-1.18-86.11%0.025-97.33%0.004-77.78%0.02-23.53%0.1350.00%0.1866.67%0.1528.57%0.09-32.00%0.17
Diluted earning per share 50.00%0.03-1,007.69%-1.18-86.11%0.025-97.33%0.004-77.78%0.02-23.53%0.1350.00%0.1866.67%0.1528.57%0.09-32.00%0.17
Other composite income -1.86%1.22M-4.31%1.24M1.3M
Other composite income of parent company owners -----1.86%1.22M-------------4.31%1.24M--------------1.3M
Other composite income of minority owners -----1.87%123.58-------------4.30%125.93--------------131.59
Total composite income -3.65%10.24M-532.80%-227.53M-48.18%25.14M-63.18%14.76M-51.83%10.63M33.75%52.57M70.10%48.51M75.48%40.09M16.73%22.06M-28.95%39.31M
Total composite income of parent company owners 89.70%5.96M-967.26%-241.24M-86.02%5.1M-97.19%893.53K-83.82%3.14M-21.86%27.82M53.04%36.45M75.04%31.83M27.14%19.44M-30.31%35.6M
Total composite income of minority owners -42.88%4.27M-44.62%13.71M66.16%20.04M67.93%13.87M185.25%7.48M567.53%24.76M156.45%12.06M77.18%8.26M-27.36%2.62M-12.65%3.71M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +2.64%
Sample Name
Sample Code
 -0.13%
Sample Name
Sample Code
 -1.05%
4
SHANGHAI PECHEM
00338
-1.56%
5
SINOPEC CORP
00386
-2.39%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +41.26%
Sample Name
Sample Code
 +31.66%
Sample Name
Sample Code
 +26.25%
4
Digital China Group
000034
+15.29%
5
Loongson Technology Corporation
688047
+12.74%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -